Jane Street’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-56,492
| Closed | -$1.85M | – | 6362 |
|
|
2019
Q4 | $1.85M | Buy |
+56,492
| New | +$1.5M | ﹤0.01% | 2034 |
|
|
2019
Q3 | – | Sell |
-21,385
| Closed | -$553K | – | 6113 |
|
|
2019
Q2 | $553K | Sell |
21,385
-7,641
| -26% | -$189K | ﹤0.01% | 3457 |
|
|
2019
Q1 | $850K | Buy |
29,026
+13,001
| +81% | +$369K | ﹤0.01% | 3020 |
|
|
2018
Q4 | $321K | Buy |
16,025
+2,216
| +16% | +$62.7K | ﹤0.01% | 3988 |
|
|
2018
Q3 | $610K | Sell |
13,809
-40,000
| -74% | -$1.61M | ﹤0.01% | 3375 |
|
|
2018
Q2 | $1.78M | Buy |
+53,809
| New | +$1.68M | ﹤0.01% | 2072 |
|
|
2018
Q1 | – | Sell |
-15,656
| Closed | -$576K | – | 5710 |
|
|
2017
Q4 | $527K | Buy |
15,656
+5,597
| +56% | +$191K | ﹤0.01% | 3106 |
|
|
2017
Q3 | $389K | Buy |
+10,059
| New | +$350K | ﹤0.01% | 3400 |
|
|
2017
Q1 | – | Sell |
-17,347
| Closed | -$457K | – | 4915 |
|
|
2016
Q4 | $366K | Sell |
17,347
-4,732
| -21% | -$112K | ﹤0.01% | 3161 |
|
|
2016
Q3 | $641K | Buy |
22,079
+9,052
| +69% | +$258K | ﹤0.01% | 2493 |
|
|
2016
Q2 | $276K | Buy |
+13,027
| New | +$330K | ﹤0.01% | 3422 |
|
|
2016
Q1 | – | Sell |
-11,252
| Closed | -$310K | – | 4853 |
|
|
2015
Q4 | $651K | Buy |
+11,252
| New | +$596K | ﹤0.01% | 2191 |
|
Other funds holding UBIO
Jane Street's UBIO Position: Q1 2020 in Review
Jane Street sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q1 2020, closing a stake of 56,492 shares — an estimated $1.85M sold.
Jane Street first reported a position in UBIO in Q4 2015 and held it in 12 quarters. The position peaked at $1.85M in Q4 2019. 1 fund tracked by Wall St. Rank holds UBIO as of Q1 2020.
- Jane Street reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
- Jane Street sold 56,492 Proshares UltraPro NASDAQ Biotechnology shares in Q1 2020, an estimated $1.85M.
- Jane Street first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q4 2015 and held it in 12 quarters.
- Jane Street's Proshares UltraPro NASDAQ Biotechnology position peaked at $1.85M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q1 2020.
Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.